198 related articles for article (PubMed ID: 29119921)
1. Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus.
Sohrab SS; El-Kafrawy SA; Mirza Z; Kamal MA; Azhar EI
Curr Pharm Des; 2018; 24(1):62-77. PubMed ID: 29119921
[TBL] [Abstract][Full Text] [Related]
2. Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method.
Nur SM; Hasan MA; Amin MA; Hossain M; Sharmin T
Interdiscip Sci; 2015 Sep; 7(3):257-65. PubMed ID: 26223545
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells.
El-Kafrawy SA; Sohrab SS; Mirza Z; Hassan AM; Alsaqaf F; Azhar EI
Molecules; 2021 Apr; 26(9):. PubMed ID: 33947034
[TBL] [Abstract][Full Text] [Related]
4. Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line.
Sohrab SS; El-Kafrawy SA; Mirza Z; Hassan AM; Alsaqaf F; Azhar EI
J Infect Public Health; 2021 Feb; 14(2):238-243. PubMed ID: 33493920
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
Nakagawa K; Narayanan K; Wada M; Makino S
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
7. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
8. The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines.
Nakagawa K; Narayanan K; Wada M; Popov VL; Cajimat M; Baric RS; Makino S
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111568
[TBL] [Abstract][Full Text] [Related]
9. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
10. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
11. [Small molecular agents against MERS-CoV infection].
Zeng XY; Lu L; Jiang SB; Liu SW
Yao Xue Xue Bao; 2015 Dec; 50(12):1520-6. PubMed ID: 27169271
[TBL] [Abstract][Full Text] [Related]
12. MERS-CoV spike protein: a key target for antivirals.
Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus.
Chan CM; Chu H; Wang Y; Wong BH; Zhao X; Zhou J; Yang D; Leung SP; Chan JF; Yeung ML; Yan J; Lu G; Gao GF; Yuen KY
J Virol; 2016 Oct; 90(20):9114-27. PubMed ID: 27489282
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
[TBL] [Abstract][Full Text] [Related]
16. Effective inhibition of MERS-CoV infection by resveratrol.
Lin SC; Ho CT; Chuo WH; Li S; Wang TT; Lin CC
BMC Infect Dis; 2017 Feb; 17(1):144. PubMed ID: 28193191
[TBL] [Abstract][Full Text] [Related]
17. Design of potential RNAi (miRNA and siRNA) molecules for Middle East respiratory syndrome coronavirus (MERS-CoV) gene silencing by computational method.
Nur SM; Hasan MA; Amin MA; Hossain M; Sharmin T
Interdiscip Sci; 2014 Nov; ():. PubMed ID: 25519155
[TBL] [Abstract][Full Text] [Related]
18. Design of potential RNAi (miRNA and siRNA) molecules for Middle East respiratory syndrome coronavirus (MERS-CoV) gene silencing by computational method.
Nur SM; Hasan MA; Amin MA; Hossain M; Sharmin T
Interdiscip Sci; 2014 Nov; ():. PubMed ID: 25373633
[TBL] [Abstract][Full Text] [Related]
19. [Development of peptidic MERS-CoV entry inhibitors].
Xia S; Wang Q; Liu SW; Lu L; Jiang SB
Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Sun Y; Zhang H; Shi J; Zhang Z; Gong R
Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
